Tax Court: Coating Aluminum Foil for Pharma Packaging Qualifies as Manufacturing for Tax Benefits The case involved a dispute over whether the coating and lamination of Aluminum Foil for pharmaceutical packaging constituted a manufacturing activity for ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tax Court: Coating Aluminum Foil for Pharma Packaging Qualifies as Manufacturing for Tax Benefits
The case involved a dispute over whether the coating and lamination of Aluminum Foil for pharmaceutical packaging constituted a manufacturing activity for tax benefits under Section 80-IB of the Income Tax Act. The Assessing Officer initially rejected the claim, but the CIT(A) and the Income Tax Appellate Tribunal upheld it. The court determined that the process resulted in a new and distinct product essential for pharmaceutical packaging, qualifying it as a manufacturing process eligible for tax benefits under Section 80-IB.
Issues involved: Determination of whether the business of coating and lamination of Alluminium Foil for pharmaceutical packaging constitutes a manufacturing activity for the purpose of claiming benefit under Section 80-IB of the Income Tax Act.
Summary: The case involved a dispute regarding the classification of the process of coating and lamination of Alluminium Foil for pharmaceutical packaging as a manufacturing activity for tax benefits under Section 80-IB of the Income Tax Act. The Assessing Officer initially rejected the claim, but the CIT(A) and the Income Tax Appellate Tribunal later upheld the claim. The key question was whether the conversion process resulted in the creation of a new and distinct product. The CIT(A) described the process as producing a new end product different from the original aluminum foil, similar to a previous Supreme Court ruling. The respondent provided a detailed chart outlining the process involved in producing Blister Foil and pharmaceutical foil from raw aluminum foil. The process included steps like shellac wash, VMCH coating, and slitting to meet the specific requirements of the pharmaceutical industry. The court found that the process, involving specialized machinery, was essential for pharmaceutical packaging and resulted in a product distinct from plain aluminum foil. Consequently, the court affirmed the lower authorities' decision, concluding that the activity qualified as a manufacturing process for tax benefits under Section 80-IB.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.